Preoperative anxiety differentiates post-surgical opioid use in patients undergoing anterior cruciate ligament reconstruction.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 40655258.
- Also identified by DOI 10.1002/jeo2.70352 and PMC identifier 12255945.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Opioids prescribed to reduce pain and aid in recovery following anterior cruciate ligament reconstruction (ACLR) may pose a risk of future substance use disorder. The purpose of this study was to determine if pre-operative anxiety and depression differentiated opioid intake following ACLR. The contribution of sex, age, and graft type to post-operative opioid usage was also explored. Data from 237 participants (<i>M</i> = 30.75 ± 13.29 years; 57% females; 76% all-soft tissue quadriceps tendon autograft) were analysed. Four-item Anxiety and Depression Patient Reported Outcomes Measurement Information System (PROMIS) scales were administered on the day of surgery, and opioid intake was assessed post-operatively. Patients were classified into 'anxious' or 'depressed' groups based on their PROMIS scores. Patients took an average of one opioid pill daily. Females with pre-operative anxiety reported significantly greater post-operative opioid intake (<i>M</i> = 4.40 ± 3.98) than females with no anxiety (<i>M</i> = 2.90 ± 3.97) (<i>W</i> = 2199, <i>p</i> = 0.03; <i>d</i> = 0.36). No other significant effects were found (<i>p</i> > 0.05). Anxiety, but not depression, was a risk factor for elevated opioid use in females undergoing ACLR. Interestingly, opioid intake between males and females, as well as by age and graft type, were comparable overall, indicating the unique influence of psychological rather than biological or demographic factors on opioid use following ACLR. Clinicians should consider biopsychosocial assessments to support preoperative opioid counselling, particularly in females with anxiety undergoing ACLR. Level IV.